Physician profile
Mitul B Kadakia
NPI 1417157652
$23,038.72
in general payments reported to CMS, 2019-2025
9 companies · $3,352 in 2025
The $3,352 reported for 2025 was more than what 77% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $322 · 2021: $1,156 · 2022: $66.86 · 2023: $1,884 · 2024: $4,448 · 2025: $3,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,968 · Food and Beverage: $4,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,967.84 |
| Food and Beverage | $4,715.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13,862.68 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $7,779.00 | 2019-2020 | |
| Abbott Laboratories | $484.47 | 2019-2023 | Mitraclip |
| Heartflow, INC. | $354.94 | 2019-2025 | Ffrct |
| Boston Scientific Corporation | $316.55 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, General - Brady |
| Medtronic, INC. | $139.51 | 2021-2024 | Corevalve Evolut R |
| Philips North America LLC | $52.42 | 2019-2020 | |
| Shockwave Medical, INC | $35.31 | 2019 | |
| Terumo Medical Corporation | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitul Kadakia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.